BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 16933325)

  • 1. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS; Arndt CA
    Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
    Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
    Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
    J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma.
    Granados-Garcia M; Luna-Ortiz K; Castillo-Oliva HA; Villavicencio-Valencia V; Herrera-Gómez A; Mosqueda-Taylor A; Aguilar-Ponce JL; Poitevin-Chacón A
    Oral Oncol; 2006 Feb; 42(2):172-6. PubMed ID: 16246617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
    Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
    Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for local control of osteosarcoma.
    DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary resection for metastatic osteosarcomas: a retrospective analysis of 21 patients.
    Pfannschmidt J; Klode J; Muley T; Hoffmann H; Dienemann H
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):120-3. PubMed ID: 16541354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection of recurrent pulmonary metastases in patients with osteosarcoma.
    Briccoli A; Rocca M; Salone M; Bacci G; Ferrari S; Balladelli A; Mercuri M
    Cancer; 2005 Oct; 104(8):1721-5. PubMed ID: 16155943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.